Skip to main content

Novasign Studio for biopharma process development

Start with one product. Build a workflow. Apply it across your portfolio. Turn your organization’s process knowledge into reusable workflows. Fewer experiments, faster decisions, and scale-up confidence built on what you already have.

The overhead that holds biopharma process teams back

The challenge is rarely a shortage of data, models or expertise. It is that none of them are structured to be reused across programs, teams or development stages, so rebuilding what already exists has become part of the job.

01

Historical knowledge stays locked in the past

Process data exists across campaigns, products and development stages, but consolidating it into a usable form takes real effort. When finding and extracting past data feels open-ended, running a new experiment becomes the path of least resistance. Knowledge gets rebuilt not by choice, but because reusing it reliably is harder than it should be.

02

In-house digital tools rarely scale beyond the person who built them

Internal models, code snippets and analytical pipelines often work well for their author. Making that capability available to the broader team, across molecules and sites, is where it consistently stalls.

03

Process teams have to become advocates for a tool, not just users of it

When a workflow does not fit how process teams actually work, even technically strong solutions fail to gain traction. People need to see clear value in their daily work before they will defend a digital tool.

04

Scale-up confidence gaps create expensive late-stage risk

Process understanding built at lab scale does not always hold at pilot or manufacturing scale. When that gap surfaces late, the consequences are concrete: delayed programs, failed batches, and unplanned engineering campaigns that could have been avoided earlier.

05

Build-versus-buy inertia slows digital progress

Data processing, model validation and maintenance, a usable interface for process teams, and adoption each become a separate project. In the meantime, teams develop workarounds that get the job done.

One connected workflow, from process data to well-justified decisions

Novasign Studio introduces a structured workflow layer across your development process and gives each step a structured home, open to extension where you need it. It does not replace your existing models, scripts or data infrastructure, it makes them reusable, reproducible and shareable across your organization. Each step is designed to fit how process teams already work rather than to require a new way of working.

1 · Plan

Design smarter experiments around the specific decision you need to make, from screening and process optimization with model-based design of experiments to intensified DoE for process characterization.

Where Novasign Studio fits in biopharma process development

One platform for all unit operations, upstream to downstream, from early-stage feasibility through technology transfer and process handoff.

Does this sound like your team?

Three kinds of situation tend to bring people to Novasign Studio. If one of them describes a problem your team has, this page is for you.

  • For VPs of process development, heads of bioprocess sciences and CMC directors

    Your team keeps redoing work it has already done.

    You have historical data, internal expertise, and development campaigns that produced real process knowledge. The problem is that the knowledge is not reusable: it lives in files, in tools, and in the heads of the people who built it. Without a structured way to capture it, it stays personal rather than shared, and the next team starts from scratch instead of building on what exists.

  • For digital CMC leads, process modelling leads and data science leads

    Your team has models and scripts that only one person can use.

    Your team has invested real effort in digital capability: data processing scripts, analytical pipelines, models. The people who built them want that work to be useful to the broader team rather than locked to their own desk. Novasign gives it a structured home, so process teams apply it directly without needing the original author to explain, translate, or be in the room.

  • For process scientists, research scientists and USP or DSP process engineers

    You need a modelling workflow you can run yourself.

    You know the biology and you know which questions need answering. What you need is a workflow you can drive yourself, without waiting for a data scientist to be available or asking them to rerun the analysis every time something changes. Novasign Studio gives you a no-code interface for day-to-day process work, with the models and scripts your colleagues built already integrated and ready to use.

Why biopharma teams choose Novasign Studio

Reuse what your organization already knows

Historical process data from prior campaigns, development runs and platform molecules already exists inside your organization. Novasign makes it usable for the next decision instead of designing another experiment to rediscover it.

Bring your own models, scripts and code

Novasign does not replace internal models or custom scripts that already work. Your existing digital assets integrate directly as shared, reusable workflows the broader team can use.

Designed for process team adoption

A no-code interface where process teams need speed, code-ready where data scientists need flexibility, and transparent model logic every stakeholder can follow. Built so the workflow gains traction across the team rather than merely being deployed.

Upstream to downstream in one workflow

The bioreactor, tangential-flow filtration (TFF) and chromatography each have a dedicated unit in Novasign Studio. Scale-up and technology transfer run in the same workflow, not in disconnected tools. Understanding from one step informs decisions in the next.

Start with a scoped proof of concept and expand

Start with one process question and your existing data. Novasign reviews the scope, delivers a clear proposal, and demonstrates value before any license decision is required. Every successful collaboration we have had with a biopharma team started this way.

How Novasign Studio compares

Build on what you already have. Your organization has valuable code, models, datasets and scientific expertise. The challenge is not a lack of digital capability, it is making that capability usable, reproducible and accessible beyond the person who created it. Novasign Studio is designed to accelerate and scale what you are already building.

Time to value

Internal build or existing tools
Months to years. Data processing, model building, user interface and adoption are each a separate project.
Novasign Studio
Weeks to a first feasibility result. The workflow infrastructure is pre-built and data processing is included.

Process team adoption

Internal build or existing tools
High risk. Tools built by data scientists often need data scientists to run them, so process teams stay dependent on whoever built the tool.
Novasign Studio
Designed for process teams. No-code interface, transparent models, built for daily use without specialist support.

Your existing code and models

Internal build or existing tools
You own them, but they are accessible only to the expert who built them.
Novasign Studio
Integrate your scripts and models directly, in a reusable format available to the whole team.

Maintenance overhead

Internal build or existing tools
Ongoing. Every new dataset, modality or site becomes a separate IT project.
Novasign Studio
Maintained by Novasign, with regular updates and on-premises or cloud deployment.

Traceable process decisions

Internal build or existing tools
Often transparent internally, but hard to document reproducibly for a regulatory dossier.
Novasign Studio
Traceable inputs, documented datasets, workflow logic and model configuration, reproducible outputs your team can stand behind.

Entry cost and risk

Internal build or existing tools
High total cost of ownership. Talent, maintenance and adoption often exceed estimates.
Novasign Studio
Scoped feasibility first, no large upfront commitment, scale once value is proven.

Start with one process question. See what your data can do.

The right starting point if you want concrete results. We work with you on a scoped proof of concept using your existing process data, so the outcome is relevant to your specific context from the first step.

  1. 1

    Scoping call

    We sign an NDA with you. Then you define one process challenge and one unit operation or workflow to focus on.

  2. 2

    Data review

    Novasign reviews your existing data and defines what the proof of concept can produce, at no cost up to this point.

  3. 3

    Proof of concept

    We build and run the workflow in Novasign Studio together with you.

  4. 4

    Results

    Clear outputs, a defined scope, and your decision on how to proceed.

  5. 5

    Handover

    The project is handed over to you in Novasign Studio, so your team continues from where the proof of concept ended.

Relevant case studies

  • 8 runs instead of 22in a process optimization campaign
    Bespark*bio

    Bespark*bio, a contract research and development organization, built a model on a reduced campaign (8 runs instead of 22) that predicted its client’s viral-vector process as well as a model built on the full campaign.

  • 5experiments to design a biosimilar CQA process
    Repligen

    Five experiments were enough to map a design space for a biosimilar monoclonal antibody, the region where glycosylation and glycation both meet their limits at once.

  • 60%higher upstream titer, and a continuous process run end to end
    ECONTI consortium

    Intensified DoE raised the upstream titer 60% over the original process conditions, model predictions guided the chromatography switching, and the estimated production cost fell to €8,465 per kg against €12,382 for fed-batch.

Questions biopharma teams ask first

What you need to get started, how many experiments it takes, whether a data science team is required, whether to begin with a proof of concept or go straight to a license, and how deployment, transparency and model ownership work, are all answered in the frequently asked questions.

Build digital capability, one workflow at a time

Start with one process question that matters to your team. Deliver a clear result, build confidence, and expand from there.